Tumour hypoxia, a feature typical for pancreatic cancer may further increase the angiogenic effect of MSC, as our in vitro data show the expression of HIF-1α by pancreatic cancer cells under hypoxic conditions, which, in turn, leads to expression and secretion of VEGF by tumour cells. This evidence concerns the gene HIF1A and neoplasm.